Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Steven Stein
Age : 53
Public asset : 10,223,743 USD
Country of residence : Unknown
Linked companies : Incyte Corporation - Kura Oncology, Inc.

Biography of Steven Stein 
Steven H. Stein holds the position of Chief Medical Officer & Executive Vice President at Incyte Corp. Dr. Stein is also on the board of Kura Oncology, Inc. In his past career Dr. Stein was Vice President-Global Oncology at GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs at Novartis Oncology, Inc. and Senior VP-US Clinical Development & Medical Affair at Novartis Pharmaceuticals Corp. Dr. Stein received a doctorate from the University of the Witwatersrand.


Current positions of Steven Stein 
Holdings of Steven Stein 
Steven Stein : Personal Network 
Most Read News 
05/04WARREN BUFFETT : Buffett's ESG snub risks alienating Wall Street
RE
05/17ELON MUSK : Bitcoin price lower after Musk tweet
RE
05/13ELON MUSK : Musk decries bitcoin's 'insane' energy use after Tesla payment U-turn
RE
05/13ELON MUSK : to the mooooonnn! And back again
RE
05/04MARTIN SORRELL : Surging demand helps Sorrell's S4 to hike profit target
RE
05/13ELON MUSK : Tesla's Musk halts use of bitcoin for car purchases
RE
05/15GEORGE SOROS : Soros buys stocks linked to Bill Hwang's Archegos collapse - Bloomberg News
RE
05/03BILL GATES : Bill and Melinda Gates to divorce, but charitable foundation to remain intact
RE
05/06DAVID SWENSEN : Yale chief investment officer Swensen dies of cancer
RE
05/07WARREN BUFFETT : Top Financial Services News of the Day
DJ
More news


© 2021 People and Ownership :   
Steven Stein : Connections 


Latest news about Steven Stein 
2020Novartis, Incyte 'Disappointed' After Planned COVID-19 Therapy Fails to Meet Target in Late-Stage Study
MT
2020INCYTE  : Phase 3 Study of Potential Treatment for COVID-19-Related Cytokine Storm Fails to Meet Primary Endpoint
MT
2020PRESS RELEASE : Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020
DJ
2020Retail Stocks Are Hot Heading Into the Holiday Season
DJ
2020How does Abenomics stack up? Reuters asked the experts
RE
More news


Popular Business Leaders 
Bernard Arnault Mary Barra Valérie Baudson Jeff Bezos Vincent Bolloré Thierry Breton Warren Buffett David Calhoun Jean-marc Chéry Tim Cook Brunello Cucinelli Clotilde Delbos Michael Dell Diego Della Valle Herbert Diess Jamie Dimon Daniel Ek Emmanuel Faber Bill Gates Charles Geschke Jitse Groen Ralph Hamers António Horta-osório Christian Klein Manfred Knof Arnaud Lagardère Jean-bernard Lévy Jack Ma Maria Martinez Carlo Messina Aditya Mittal Rupert Murdoch Elon Musk Alexander Novak Andrea Orcel Bernd Osterloh François Pinault Hasso Plattner Alessandro Profumo Alexandre Ricard Gilles Schnepp Carlos Slim Pascal Soriot Robert Allen Stanford Carlos Tavares François Villeroy De Galhau Chris Vogelzang Mark Zuckerberg Luca De Meo
A-Z Business Leaders